Kuwer Industries (530421)

Asset Play

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹15.83
Market Cap₹14.37 Cr
P/E Ratio93.33
ROCE6.45%
ROE-6.21%
Dividend Yield0%
Profit Growth-82.69%
Debt/Equity
Sales Growth-9.91%
52-Week Range₹7.38 — ₹15.83
SectorChemicals & Petrochemicals
Book Value₹20.56

Strengths

Concerns

AI Analysis

At ₹15.83, Kuwer Industries is a classic cigar butt—buyable at a discount to its stated book value of ₹20.56, meaning every rupee I pay gets me about ₹1.30 of assets. But we must be careful. This is not a wonderful business. It is a commodity chemical producer with no pricing power and no durable moat. Sales have shrunk by 9.91% and profits have collapsed by 82.69%. Return on equity is negative at -6.21%, so this business is destroying shareholder value, not creating it. The Piotroski F-score of 3/9 tells me the financial condition is deteriorating. The latest quarter shows revenue of ₹14 Cr but net profit of essentially zero—there is no earnings engine working. At a P/E of 93.33, the market is paying a rich multiple for negligible profits, which makes no sense from an earnings perspective. However, the asset angle is interesting. With a P/B of 0.77, I am getting assets at a 23% discount. The question is whether those assets are productive or merely idle. ROCE at 6.45% is below what I would want from a quality business, but it is positive—so the capital employed is generating some return. This looks like a possible asset play, not a growth story. I would need to understand the quality of the book value, the debt situation (not disclosed here), and whether management can redeploy capital. There is no dividend to compensate me while I wait. In true Graham fashion, I demand a margin of safety and would only invest if I could verify the liquidation value. Given the weak fundamentals, I would not touch it unless the price drops further or the book value proves to be real.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer